Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 33, 2003 - Issue 6
67
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Functional characterization of three human cytochrome P450 2E1 variants with amino acid substitutions

, , , , , , , & show all
Pages 575-586 | Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Benoit Roig, Wissem Mnif, Aziza Ibn Hadj Hassine, Ines Zidi, Sandrine Bayle, Aghleb Bartegi & Olivier Thomas. (2013) Endocrine Disrupting Chemicals and Human Health Risk Assessment: A Critical Review. Critical Reviews in Environmental Science and Technology 43:21, pages 2297-2351.
Read now
Pat Neafsey, Gary Ginsberg, Dale Hattis, Douglas O. Johns, Kathryn Z. Guyton & Babasaheb Sonawane. (2009) Genetic Polymorphism in CYP2E1: Population Distribution of CYP2E1 Activity. Journal of Toxicology and Environmental Health, Part B 12:5-6, pages 362-388.
Read now
Gary Ginsberg, Susan Smolenski, Patricia Neafsey, Dale Hattis, Katy Walker, Kathryn Z. Guyton, Douglas O. Johns & Babasaheb Sonawane. (2009) The Influence of Genetic Polymorphisms on Population Variability in Six Xenobiotic-Metabolizing Enzymes. Journal of Toxicology and Environmental Health, Part B 12:5-6, pages 307-333.
Read now
Grover P Miller. (2008) Advances in the interpretation and prediction of CYP2E1 metabolism from a biochemical perspective. Expert Opinion on Drug Metabolism & Toxicology 4:8, pages 1053-1064.
Read now
Y. Guo, Y. Wang, D. Si, P. J. Fawcett, D. Zhong & H. Zhou. (2005) Catalytic activities of human cytochrome P450 2C9*1, 2C9*3 and 2C9*13. Xenobiotica 35:9, pages 853-861.
Read now

Articles from other publishers (20)

Birgitte Lindeman, Ylva Johansson, Mathilda Andreassen, Trine Husøy, Hubert Dirven, Tim Hofer, Helle K. Knutsen, Ida H. Caspersen, Kristine Vejrup, Ragnhild E. Paulsen, Jan Alexander, Anna Forsby & Oddvar Myhre. (2021) Does the food processing contaminant acrylamide cause developmental neurotoxicity? A review and identification of knowledge gaps. Reproductive Toxicology 101, pages 93-114.
Crossref
Justyna Ber, Paweł Wiczling, Marcin Hołysz, Agnieszka Klupczyńska, Alicja Bartkowska‐Śniatkowska, Krzysztof Bieda, Piotr Smuszkiewicz, Małgorzata Nowicka, Łukasz Żurański, Paweł Sobczyński, Jan Matysiak, Edmund Grześkowiak & Agnieszka Bienert. (2020) Population Pharmacokinetic Model of Dexmedetomidine in a Heterogeneous Group of Patients. The Journal of Clinical Pharmacology 60:11, pages 1461-1473.
Crossref
Ting Wang, Huihui Du, Jingsong Ma, Lu Shen, Muyun Wei, Xianglong Zhao, Luan Chen, Mo Li, Guorong Li, Qinghe Xing, Lin He & Shengying Qin. (2020) Functional characterization of the chlorzoxazone 6-hydroxylation activity of human cytochrome P450 2E1 allelic variants in Han Chinese. PeerJ 8, pages e9628.
Crossref
Huihui Du, Zhiyun Wei, Yucai Yan, Yuyu Xiong, Xiaoqing Zhang, Lu Shen, Yunfeng Ruan, Xi Wu, Qingqing Xu, Lin He & Shengying Qin. (2016) Functional Characterization of Human CYP2C9 Allelic Variants in COS-7 Cells. Frontiers in Pharmacology 7.
Crossref
Avanthika Venkatachalam, Abhinav Parashar & Kelath Murali Manoj. (2016) Functioning of drug-metabolizing microsomal cytochrome P450s: In silico probing of proteins suggests that the distal heme ‘active site’ pocket plays a relatively ‘passive role’ in some enzyme-substrate interactions. In Silico Pharmacology 4:1.
Crossref
F. Peter Guengerich. 2015. Cytochrome P450. Cytochrome P450 523 785 .
Martin Otto Behm. 2013. Pediatric Drug Development. Pediatric Drug Development 292 305 .
Ran Huo, Kefu Tang, Zhiyun Wei, Lu Shen, Yuyu Xiong, Xi Wu, Jiamin Niu, Xia Han, Zhengan Tian, Lun Yang, Guoyin Feng, Lin He & Shengying Qin. (2012) Genetic Polymorphisms in CYP2E1: Association with Schizophrenia Susceptibility and Risperidone Response in the Chinese Han Population. PLoS ONE 7:5, pages e34809.
Crossref
Vita Dolžan. 2012. Pharmacogenetics and Individualized Therapy. Pharmacogenetics and Individualized Therapy 13 80 .
Johannes N. van den Anker, Matthias Schwab & Gregory L. Kearns. 2011. Pediatric Clinical Pharmacology. Pediatric Clinical Pharmacology 51 75 .
Matthew Pratt-Hyatt, Hsia-lien Lin & Paul F. Hollenberg. (2010) Mechanism-Based Inactivation of Human CYP2E1 by Diethyldithocarbamate. Drug Metabolism and Disposition 38:12, pages 2286-2292.
Crossref
Nobumitsu Hanioka, Maki Yamamoto, Toshiko Tanaka-Kagawa, Hideto Jinno & Shizuo Narimatsu. (2009) Functional characterization of human cytochrome P450 2E1 allelic variants: in vitro metabolism of benzene and toluene by recombinant enzymes expressed in yeast cells. Archives of Toxicology 84:5, pages 363-371.
Crossref
C. Viaggi, F. Vaglini, C. Pardini, A. Caramelli & G.U. Corsini. (2009) MPTP-induced model of Parkinson's disease in cytochrome P450 2E1knockout mice. Neuropharmacology 56:8, pages 1075-1081.
Crossref
Nur Duale, Thomas Bjellaas, Jan Alexander, Georg Becher, Margaretha Haugen, Jan Erik Paulsen, Henrik Frandsen, Pelle Thonning Olesen & Gunnar Brunborg. (2009) Biomarkers of Human Exposure to Acrylamide and Relation to Polymorphisms in Metabolizing Genes. Toxicological Sciences 108:1, pages 90-99.
Crossref
Nobumitsu Hanioka, Maki Yamamoto, Hiroyuki Iwabu, Hideto Jinno, Toshiko Tanaka-Kagawa, Shinsaku Naito, Takefumi Shimizu, Kazufumi Masuda, Takashi Katsu & Shizuo Narimatsu. (2007) Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes. Life Sciences 81:19-20, pages 1436-1445.
Crossref
Ryan SwinneyStephanie HsuGail Tomlinson. (2023) Phase I and Phase II Enzyme Polymorphisms and Childhood Cancer. Journal of Investigative Medicine 54:6, pages 303-320.
Crossref
Yeomin Yoon, Hyung-Doo Park, Kyoung Un Park, Jin Q. Kim, Yoon-Seok Chang & Junghan Song. (2006) Associations between CYP2E1 promoter polymorphisms and plasma 1,3-dimethyluric acid/theophylline ratios. European Journal of Clinical Pharmacology 62:8, pages 627-631.
Crossref
Yingjie Guo, Yifan Zhang, Ying Wang, Xiaoyan Chen, Dayong Si, Dafang Zhong, J. Paul Fawcett & Hui Zhou. (2005) ROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9 * 3 AND CYP2C9 * 13) IN THE METABOLISM OF LORNOXICAM IN HUMANS . Drug Metabolism and Disposition 33:6, pages 749-753.
Crossref
Hiroyuki Hichiya, Toshiko Tanaka-Kagawa, Akiko Soyama, Hideto Jinno, Satoru Koyano, Noriko Katori, Erika Matsushima, Shigehisa Uchiyama, Hiroshi Tokunaga, Hideo Kimura, Narihiro Minami, Masaaki Katoh, Kenji Sugai, Yu-ichi Goto, Tomohide Tamura, Noboru Yamamoto, Yuichiro Ohe, Hideo Kunitoh, Hiroshi Nokihara, Teruhiko Yoshida, Hironobu Minami, Nagahiro Saijo, Masanori Ando, Shogo Ozawa, Yoshiro Saito & Jun-ichi Sawada. (2005) FUNCTIONAL CHARACTERIZATION OF FIVE NOVEL CYP2C8 VARIANTS, G171S, R186X, R186G, K247R, AND K383N, FOUND IN A JAPANESE POPULATION. Drug Metabolism and Disposition 33:5, pages 630-636.
Crossref
Silvio Bandiera, Simone Weidlich, Volker Harth, Peter Broede, Yun Ko & Thomas Friedberg. (2005) Proteasomal Degradation of Human CYP1B1: Effect of the Asn453Ser Polymorphism on the Post-Translational Regulation of CYP1B1 Expression. Molecular Pharmacology 67:2, pages 435-443.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.